Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma-Reference-Cited by-同舟云学术

Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma

Published:2012-06 Issue:6 Volume:21 Page:723-737
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Yang Yibin,Shaffer Arthur L.,Emre N.C. Tolga,Ceribelli Michele,Zhang Meili,Wright George,Xiao Wenming,Powell John,Platig John,Kohlhammer Holger,Young Ryan M.,Zhao Hong,Yang Yandan,Xu Weihong,Buggy Joseph J.,Balasubramanian Sriram,Mathews Lesley A.,Shinn Paul,Guha Rajarshi,Ferrer Marc,Thomas Craig,Waldmann Thomas A.,Staudt Louis M.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference54 articles.

1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000

2. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls;Baud;Nat. Rev. Drug Discov.,2009

3. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1;Brass;Genes Dev.,1996

4. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers;Brass;EMBO J.,1999

5. Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells;Davis;J. Exp. Med.,2001

Cited by 447 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomics in Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation;Nature Communications;2024-08-08

3. IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma;Cancer Cell;2024-07

4. Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma;Journal of Medicinal Chemistry;2024-06-26

5. CREB1 promotes expression of immune checkpoint HLA-E leading to immune escape in multiple myeloma;Leukemia;2024-06-20